These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 39046727)
1. Dapagliflozin and Right Ventricular-Pulmonary Vascular Interaction in Heart Failure With Preserved Ejection Fraction: A Secondary Analysis of a Randomized Clinical Trial. Reddy YNV; Carter RE; Sorimachi H; Omar M; Popovic D; Alogna A; Jensen MD; Borlaug BA JAMA Cardiol; 2024 Sep; 9(9):843-851. PubMed ID: 39046727 [TBL] [Abstract][Full Text] [Related]
2. Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial. Tada A; Burkhoff D; Naser JA; Harada T; Pourmussa B; Reddy YNV; Jensen MD; Carter RE; Demmer RT; Testani JM; Chirinos JA; Borlaug BA Circulation; 2024 Sep; 150(13):997-1009. PubMed ID: 39101201 [TBL] [Abstract][Full Text] [Related]
3. Sex-Related Differences in Dynamic Right Ventricular-Pulmonary Vascular Coupling in Heart Failure With Preserved Ejection Fraction. Singh I; Oliveira RKF; Heerdt PM; Pari R; Systrom DM; Waxman AB Chest; 2021 Jun; 159(6):2402-2416. PubMed ID: 33388286 [TBL] [Abstract][Full Text] [Related]
4. Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial. Borlaug BA; Reddy YNV; Braun A; Sorimachi H; Omar M; Popovic D; Alogna A; Jensen MD; Carter R Circulation; 2023 Sep; 148(10):834-844. PubMed ID: 37534453 [TBL] [Abstract][Full Text] [Related]
5. Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction. Andersen MJ; Hwang SJ; Kane GC; Melenovsky V; Olson TP; Fetterly K; Borlaug BA Circ Heart Fail; 2015 May; 8(3):542-50. PubMed ID: 25857307 [TBL] [Abstract][Full Text] [Related]
6. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial. Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860 [TBL] [Abstract][Full Text] [Related]
7. Right Ventricular-Arterial Uncoupling During Exercise in Heart Failure With Preserved Ejection Fraction: Role of Pulmonary Vascular Dysfunction. Singh I; Rahaghi FN; Naeije R; Oliveira RKF; Systrom DM; Waxman AB Chest; 2019 Nov; 156(5):933-943. PubMed ID: 31103695 [TBL] [Abstract][Full Text] [Related]
8. Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction. Omar M; Jensen J; Frederiksen PH; Kistorp C; Videbæk L; Poulsen MK; Möller S; Ali M; Gustafsson F; Køber L; Borlaug BA; Schou M; Møller JE J Am Coll Cardiol; 2020 Dec; 76(23):2740-2751. PubMed ID: 33272368 [TBL] [Abstract][Full Text] [Related]
9. The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction. Reddy YNV; Obokata M; Wiley B; Koepp KE; Jorgenson CC; Egbe A; Melenovsky V; Carter RE; Borlaug BA Eur Heart J; 2019 Dec; 40(45):3721-3730. PubMed ID: 31609443 [TBL] [Abstract][Full Text] [Related]
10. Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction: A Substudy of the Empire HF Randomized Clinical Trial. Omar M; Jensen J; Ali M; Frederiksen PH; Kistorp C; Videbæk L; Poulsen MK; Tuxen CD; Möller S; Gustafsson F; Køber L; Schou M; Møller JE JAMA Cardiol; 2021 Jul; 6(7):836-840. PubMed ID: 33404637 [TBL] [Abstract][Full Text] [Related]
11. Load-Independent Systolic and Diastolic Right Ventricular Function in Heart Failure With Preserved Ejection Fraction as Assessed by Resting and Handgrip Exercise Pressure-Volume Loops. Rommel KP; von Roeder M; Oberueck C; Latuscynski K; Besler C; Blazek S; Stiermaier T; Fengler K; Adams V; Sandri M; Linke A; Schuler G; Thiele H; Lurz P Circ Heart Fail; 2018 Feb; 11(2):e004121. PubMed ID: 29449367 [TBL] [Abstract][Full Text] [Related]
12. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial. Nassif ME; Windsor SL; Borlaug BA; Kitzman DW; Shah SJ; Tang F; Khariton Y; Malik AO; Khumri T; Umpierrez G; Lamba S; Sharma K; Khan SS; Chandra L; Gordon RA; Ryan JJ; Chaudhry SP; Joseph SM; Chow CH; Kanwar MK; Pursley M; Siraj ES; Lewis GD; Clemson BS; Fong M; Kosiborod MN Nat Med; 2021 Nov; 27(11):1954-1960. PubMed ID: 34711976 [TBL] [Abstract][Full Text] [Related]
13. RV Contractile Function and its Coupling to Pulmonary Circulation in Heart Failure With Preserved Ejection Fraction: Stratification of Clinical Phenotypes and Outcomes. Guazzi M; Dixon D; Labate V; Beussink-Nelson L; Bandera F; Cuttica MJ; Shah SJ JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt B):1211-1221. PubMed ID: 28412423 [TBL] [Abstract][Full Text] [Related]
14. Right ventricular response to pulsatile load is associated with early right heart failure and mortality after left ventricular assist device. Grandin EW; Zamani P; Mazurek JA; Troutman GS; Birati EY; Vorovich E; Chirinos JA; Tedford RJ; Margulies KB; Atluri P; Rame JE J Heart Lung Transplant; 2017 Jan; 36(1):97-105. PubMed ID: 27469015 [TBL] [Abstract][Full Text] [Related]
15. Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis. Beale AL; Nanayakkara S; Segan L; Mariani JA; Maeder MT; van Empel V; Vizi D; Evans S; Lam CSP; Kaye DM JACC Heart Fail; 2019 Mar; 7(3):239-249. PubMed ID: 30819380 [TBL] [Abstract][Full Text] [Related]
16. Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction. Borlaug BA; Kane GC; Melenovsky V; Olson TP Eur Heart J; 2016 Nov; 37(43):3293-3302. PubMed ID: 27354047 [TBL] [Abstract][Full Text] [Related]
17. Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction. Reddy YNV; Andersen MJ; Obokata M; Koepp KE; Kane GC; Melenovsky V; Olson TP; Borlaug BA J Am Coll Cardiol; 2017 Jul; 70(2):136-148. PubMed ID: 28683960 [TBL] [Abstract][Full Text] [Related]
18. Effects of Sodium-Glucose Co-Transporter-2 Inhibition on Pulmonary Arterial Stiffness and Right Ventricular Function in Heart Failure with Reduced Ejection Fraction. Çamcı S; Yılmaz E Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013595 [TBL] [Abstract][Full Text] [Related]
19. Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial. Patel RB; Silvestry FE; Komtebedde J; Solomon SD; Hasenfuß G; Litwin SE; Borlaug BA; Price MJ; Kawash R; Hummel SL; Cutlip DE; Leon MB; van Veldhuisen DJ; Rieth AJ; McKenzie S; Bugger H; Mazurek JA; Kapadia SR; Vanderheyden M; Ky B; Shah SJ JAMA Cardiol; 2024 Jun; 9(6):507-522. PubMed ID: 38630494 [TBL] [Abstract][Full Text] [Related]
20. Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF Trial. Nassif ME; Qintar M; Windsor SL; Jermyn R; Shavelle DM; Tang F; Lamba S; Bhatt K; Brush J; Civitello A; Gordon R; Jonsson O; Lampert B; Pelzel J; Kosiborod MN Circulation; 2021 Apr; 143(17):1673-1686. PubMed ID: 33550815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]